97298596 - GC BIOSCIENCE

Information

• Trademark
• 97298596

• Source

• Serial Number

  97298596

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 07, 2022
  2 years ago

• Transaction Date

  January 10, 2025
  a month ago

• Status Date

  June 25, 2024
  8 months ago

• Published for Opposition Date

  December 13, 2022
  2 years ago

• Location Date

  February 07, 2023
  2 years ago

• Status Code

  732

• Current Location

  INTENT TO USE SECTION

  Employee Name

  RINKER, ANTHONY

• Attorney Docket Number

  5734-0392TM

  Attorney Name

  Kwang Yup Chae

  Law Office Assigned Location Code

  L20

• Owners

  • GREEN CROSS HOLDINGS CORPORATION

Case File Statements

• DM0000: The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the stylized wording "GC Bioscience" in dark blue; the color white is not claimed as a feature of the mark and represents background and transparent areas only.
• GS0051: Medicines for humans used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Medicines for humans, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Medicated plasters; Vaccines; Biological preparations for medical or veterinary purposes, namely, biological preparations used for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombocytopenia, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Immunodeficiency disease, Human Immunodeficiency Virus, rare disease, Hunter Syndrome, Hemophilia, Hemophilia A, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, virus infection, influenza, bacterial infection and chronic pain; Biological preparations for medical or veterinary purposes, namely, blood plasma-derivatives, namely, albumins, immunoglobulins, and blood clotting factors; Dietary and nutritional supplements
• CC0000: The color(s) green, yellow, orange, red, and dark blue is/are claimed as a feature of the mark.
• GS0351: Wholesale distributorships and retail store services featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Wholesale store services featuring biological preparations for medical purposes; Retail store services featuring biological preparations for medical purposes; Retail store services featuring pharmaceutical preparations for the treatment of cells; Retail store services featuring medical instruments; Retail store services featuring medical apparatus; Retail store services featuring medical genetic analyzer; Retail store services featuring electromedical diagnostic instruments; Wholesale store services featuring pharmaceutical preparations for the treatment of cells; Wholesale store services featuring medical instruments; Wholesale store services featuring medical apparatus; Wholesale store services featuring medical genetic analyzer; Wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrial, institutional, commercial and janitorial equipment and supplies; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses
• DS0000: "BIOSCIENCE"
• GS0421: Research and development of vaccines and medicines; Research and development, laboratory and scientific research in the field of pharmaceuticals, blood plasma preparations, recombinant proteins and antibodies; Conducting clinical studies of medicines for medical research purposes; Clinical research in the nature of performing biopsies for medical research; Product research and development of medical products; Conducting technical project studies, namely, engineering services in the nature of technical project planning and design engineering of medical products; Testing, inspection or research of pharmaceuticals; Scientific research relating to biology; Scientific research in the field of genetic engineering; Research and development of technology for biotechnology; Scientific research in the fields of biomedicine; Laboratory research in the field of biology; Product development of cell therapy products; Drug discovery services; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of gene analysis; Medical studies, namely, medical laboratory services; Research and development of technology for medicinal chemical manufacturing; Medical research services relating to clinical data

Case File Event Statements

• 3/10/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 3/11/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/28/2022 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 11/4/2022 - 2 years ago

  9 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/12/2022 - 2 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 11/4/2022 - 2 years ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 11/4/2022 - 2 years ago

  6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 11/4/2022 - 2 years ago

  7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 11/4/2022 - 2 years ago

  8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 11/4/2022 - 2 years ago

  10 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 11/4/2022 - 2 years ago

  11 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 11/4/2022 - 2 years ago

  12 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 11/4/2022 - 2 years ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 11/4/2022 - 2 years ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/23/2022 - 2 years ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/13/2022 - 2 years ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/13/2022 - 2 years ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/7/2023 - 2 years ago

  18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/10/2023 - a year ago

  19 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/10/2023 - a year ago

  20 - SOU EXTENSION 1 FILED Type: EXT1

• 3/10/2023 - a year ago

  21 - SOU EXTENSION 1 GRANTED Type: EX1G

• 3/14/2023 - a year ago

  22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/5/2024 - a year ago

  23 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/5/2024 - a year ago

  24 - SOU EXTENSION 2 FILED Type: EXT2

• 2/5/2024 - a year ago

  25 - SOU EXTENSION 2 GRANTED Type: EX2G

• 2/7/2024 - a year ago

  26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/25/2024 - 8 months ago

  27 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/25/2024 - 8 months ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/25/2024 - 8 months ago

  28 - SOU EXTENSION 3 FILED Type: EXT3

• 1/10/2025 - a month ago

  31 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/25/2024 - 8 months ago

  29 - SOU EXTENSION 3 GRANTED Type: EX3G